Minimal residual disease with wt1 gene expression blocked by wt1 antisense oligonucleotides in vitro.
- Author:
Lu YANG
1
;
Yue-An CAO
;
Chao-Sheng PENG
;
Jing XIA
;
Wen-Luo ZHANG
;
Li TIAN
Author Information
1. Department of Special Necd, Navy General Hospital, Beijing 100037, China.
- Publication Type:Journal Article
- MeSH:
Gene Expression;
HL-60 Cells;
Humans;
K562 Cells;
Neoplasm, Residual;
genetics;
Oligonucleotides, Antisense;
genetics;
WT1 Proteins;
genetics
- From:
Journal of Experimental Hematology
2011;19(1):50-53
- CountryChina
- Language:Chinese
-
Abstract:
The aim of this study was to investigate the expression of wt1 gene and the changes of gene expression in minimal residual disease (MRD) models (K562, HL-60 cell lines) and acute leukemia (AL) patients through inhibiting the expression of wt1 gene by antisense oligonucleotides (ASO). The bone marrow (BM) of 56 AL patients with complete remission (CR) was collected, then the BM samples with positive expression of wt1 gene were screened by RT-PCR. The cells of MRD model and screened wt1 gene positive samples were cultured and treated by ASO, then the changes of wt1 gene expression were detected. The results indicated that the sensitivity of wt1 gene was 10(-3)-10(-4), and the positive rate of BM wt1 gene expression in 56 AL patients with CR was 16%. After BM of 9 AL CR patients with MRD and MRD model (K562, HL-60 cells) expressing wt1 gene were treated by ASO, it was found that the wt1 expression in ASO group was blocked, while wt1 gene could be still detected in both sense oligonucleotides (SO) and control groups. It is concluded that ASO can obstruct the expression of wt1 gene on the residual leukemia cells in vitro.
